🇧🇷Brazil

Ruptura de Estoque e Perda de Vendas (Stock-Out-Induced Revenue Loss)

2 verified sources

Definition

Manual or poor inventory planning leads to systematic unavailability of high-demand products. Source [3] warns: 'Você não pode apenas repor o produto vendido pois poderá estar ignorando uma demanda maior.' Source [2] identifies 'Minimizar Falta de Estoque' as a key automation benefit. When customers cannot find needed medications, they switch to competing pharmacies.

Key Findings

  • Financial Impact: Estimated: 5–10% of monthly revenue per location. Average pharmacy daily revenue: R$ 5,000–20,000. Monthly loss: R$ 7,500–60,000 per pharmacy.
  • Frequency: Recurring; especially during seasonal peaks (winter cold/flu, summer allergies)
  • Root Cause: Poor demand forecasting; inadequate lead-time buffer stock; lack of sales data analytics; supplier delays not accounted for

Why This Matters

The Pitch: Brazilian retail pharmacies lose 5–10% of potential revenue through preventable stock-outs. Predictive inventory analytics (source [2]: 'Previsão de demanda') recovers lost transactions and customer loyalty.

Affected Stakeholders

Pharmacy Manager, Purchasing Manager, Sales Staff

Deep Analysis (Premium)

Financial Impact

Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.

Unlock to reveal

Current Workarounds

Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.

Unlock to reveal

Get Solutions for This Problem

Full report with actionable solutions

$99$39
  • Solutions for this specific pain
  • Solutions for all 15 industry pains
  • Where to find first clients
  • Pricing & launch costs
Get Solutions Report

Methodology & Sources

Data collected via OSINT from regulatory filings, industry audits, and verified case studies.

Evidence Sources:

Related Business Risks

Perda por Vencimento de Medicamentos (Product Expiration Waste)

Estimated: R$ 2,000–25,000 annually per pharmacy (2–5% of typical inventory value of R$ 100,000–500,000). Pharmacy chains with 10+ locations: R$ 20,000–250,000+ annually.

Custo de Gestão Manual de Estoque (Manual Inventory Management Labor Cost)

Estimated: R$ 1,000–4,000 monthly per pharmacy location (20–40 hours × R$ 50–100/hour). Multi-location chains: R$ 10,000–40,000+ monthly for 10 locations.

Multas ANVISA por Falha no Controle de Estoque (ANVISA Fines for Inventory Control Violations)

Estimated ANVISA fine: R$ 5,000–100,000+ per violation. Average fine for first-time inventory control violation: R$ 10,000–50,000. Repeated violations: escalation to license suspension (potentially R$ 500,000+ revenue impact annually).

Erro de Decisão de Compra por Falta de Visibilidade de Dados (Poor Purchasing Decisions Due to Data Gaps)

Estimated: 10–20% of annual inventory value tied up in excess slow-moving stock. Average pharmacy inventory: R$ 100,000–500,000. Excess working capital tied up: R$ 10,000–100,000+. Carrying cost (rent, shrinkage, deterioration): 15–25% annually = R$ 1,500–25,000 per pharmacy annually.

Multa por Violação de LGPD e Privacidade do Consumidor

R$ 8,497,500.00 (confirmed fine); potential industry exposure: R$ 50,000–R$ 3,000,000 per administrative proceeding depending on scale and intent.

Risco de Recusa de Cobertura de Plano de Saúde por Violação de Dados Sensíveis

Per-customer litigation cost: R$ 10,000–R$ 50,000; churn impact: 2–5% customer base loss annually; class action risk: R$ 5,000,000+.

Request Deep Analysis

🇧🇷 Be first to access this market's intelligence